Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Alcohol's Role in Progression of HBV-Related Liver Disease
January 2025
Alcohol consumption exacerbates the risk of cirrhosis and hepatocellular carcinoma, promoting hepatitis B virus replication and weakening immunity.
Read more
12 Dec 2024
How to Reduce Liver Fat Through Targeted Dietary Interventions
Lifestyle modifications, particularly dietary changes, have shown potential in reversing MASLD and steatohepatitis.
8 Dec 2024
Exploring Flaxseed and Fasting for MASLD Treatment
A recent clinical trial investigated combining time-restricted feeding and flaxseed for MASLD treatment.
7 Dec 2024
New Strategies for Monitoring Liver Fibrosis in Hepatitis C
Among serum biomarkers, the FIB-4 and APRI scores are widely recognised for assessing advanced fibrosis and cirrhosis.
4 Dec 2024
Clinical Trial Validates New MASLD Drug Therapy
This study examined the efficacy and safety of pemafibrate in 360 patients with MASLD and hypertriglyceridaemia.
2 Dec 2024
Non-Invasive Risk Score Predicts Clinical Events in Primary Sclerosing Cholangitis
The study involved 419 patients, aged 18–75, with noncirrhotic PSC, who were randomly assigned to receive either cilofexor or a placebo over 96 weeks.
24 Nov 2024
AI Revolutionises Early Detection of Liver Disease
A new study reveals that AI can identify early-stage metabolic-associated steatotic liver disease using electronic health records.
18 Nov 2024
Neutrophil Extracellular Traps Imbalance Linked to Portal Vein Thrombosis
This study assessed neutrophil extracellular traps and DNase activity in patients with chronic hepatitis B-related decompensated cirrhosis to determine their relationship with PVT.
12 Nov 2024
Targeted Hepatitis C Efforts Show Promising Results in Spain
In Spain, HCV prevalence among people experiencing homelessness has declined significantly, from 7.2% in 2019 to 3.4% in 2023.
Loading posts...
« Previous
1
2
3
4
5
…
20
Next »